---
schema_version: "secwatch.filing_event.v1"
accession: "0000926617-26-000007"
form_type: "8-K"
ticker: "AWHL"
cik: "0000926617"
company_name: "Aspira Women's Health Inc."
filed_at: "2026-01-30T23:59:59+00:00"
generated_at: "2026-05-16T06:13:07.775905+00:00"
event_type: "debt"
sentiment: "neutral"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# Aspira Women's Health enters $1.05M subordinated loan with Agile Lending, maturing Aug 2026

## Summary
- Principal of $1,050,000 plus $441,000 interest due; matures August 26, 2026.
- Loan subordinated to all Senior Indebtedness; secured by substantially all assets.
- Proceeds used for general corporate purposes; $50,000 administrative agent fee.
- Financial covenants partially waived; financing statement only filed upon default.
- Agile Lending LLC as lead lender; Agile Capital Funding LLC as collateral agent.

## SEC filing metadata
- accession: 0000926617-26-000007
- form_type: 8-K
- ticker: AWHL
- cik: 0000926617
- company_name: Aspira Women's Health Inc.
- filed_at: 2026-01-30T23:59:59+00:00
- event_type: debt
- sentiment: neutral
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 1.01, 2.03, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/926617/000092661726000007/0000926617-26-000007-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/926617/000092661726000007/awhl-20260130x8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000926617-26-000007
- JSON: https://secwatch.observer/filing/0000926617-26-000007.json
- Plain text: https://secwatch.observer/filing/0000926617-26-000007.txt

## Key facts
- Debt Financings
  Aspira Women's Health Inc. incurred term loan of $1,050,000 with Agile Lending, LLC at interest charges of $441,000 (assuming all payments are made on time) maturing August 26, 2026.
  - Instrument: term loan
  - Principal: $1,050,000
  - Counterparty: Agile Lending, LLC
  - Rate: interest charges of $441,000 (assuming all payments are made on time)
  - Maturity: August 26, 2026
  - Event: incurrence
  source text: On January 30, 2026, Aspira Women’s Health Inc. (the “ Company ”) entered into a Subordinated Business Loan and Security Agreement (the “ Subordinated Loan Agreement ”) with Agile Lending, LLC, as lead lender, and Agile Capital Funding, LLC, as collateral agent, pursuant to which the Lenders (as such term is defined in the Subordinary Loan Agreement) agreed to make a secured term loan to the Company and certain subsidiary co-borrowers. The Subordinated Loan Agreement is dated as of January 30, 2026. ​ The term loan is evidenced by a Subordinated Secured Promissory Note (the “ Note ”) in the form attached to the Subordinated Loan Agreement. The Note was issued in the principal amount of $1,050,000, will include interest charges of $441,000 (assuming all payments are made on time), and is scheduled to mature on August 26, 2026.
  evidence_url: https://www.sec.gov/Archives/edgar/data/926617/000092661726000007/0000926617-26-000007-index.htm
- Material Agreements
  Aspira Women's Health Inc. entered into Subordinated Loan Agreement with Agile Lending, LLC, as lead lender, and Agile Capital Funding, LLC, as collateral agent valued at $1,050,000 (effective 2026-01-30).
  - Action: entry
  - Agreement: credit facility
  - Counterparty: Agile Lending, LLC, as lead lender, and Agile Capital Funding, LLC, as collateral agent
  - Value: $1,050,000
  - Effective: 2026-01-30
  source text: On January 30, 2026, Aspira Women’s Health Inc. (the “ Company ”) entered into a Subordinated Business Loan and Security Agreement (the “ Subordinated Loan Agreement ”) with Agile Lending, LLC, as lead lender, and Agile Capital Funding, LLC, as collateral agent
  evidence_url: https://www.sec.gov/Archives/edgar/data/926617/000092661726000007/0000926617-26-000007-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.